Hofseth Biocare ASA: Disclosure of large shareholdings in Hofseth BioCare ASA

On 24 May 2019, 3,400,000 shares were sold by the Bonafide Global Fish Fund and purchased by the Bonafide Investment Fund - Best Catches I.

IFM Independent Fund Management AG (“IFM”) acts as trustee for both funds, Bonafide Global Fish Fund and Bonafide Investment Fund - Best Catches I, thus there are no changes in voting rights or number of shares held by Bonafide.

The total shareholding in Hofseth BioCare ASA ("HBC") under management by IFM is unchanged at 21,086,060 shares, equal to 7.15 %. Bonafide total shareholdings is 73,697,907 shares, equal to approx. 25 % of the total outstanding shares and voting rights in HBC.

For further information, please contact:
Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Mob: +47 93632966
E-mail: joo@hofsethbiocare.no 

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act